Singular Genomics | 4: Statement of changes in beneficial ownership of securities-Officer Ropp Sam
Singular Genomics | 4: Statement of changes in beneficial ownership of securities-Officer Meeter Dalen
Singular Genomics | 4: Statement of changes in beneficial ownership of securities-Officer Glezer Eli N.
Singular Genomics | 4: Statement of changes in beneficial ownership of securities-Officer Spaventa Andrew
Singular Genomics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Eli Glezer(6.6%)
Singular Genomics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Andrew Spaventa(7.9%)
Singular Genomics | 4: Statement of changes in beneficial ownership of securities-Officer Ropp Sam
Singular Genomics | 4: Statement of changes in beneficial ownership of securities-Officer Ghai Jyotsna
Singular Genomics | 4: Statement of changes in beneficial ownership of securities-Officer Meeter Dalen
Singular Genomics | 4: Statement of changes in beneficial ownership of securities-Officer Glezer Eli N.
Singular Genomics | 4: Statement of changes in beneficial ownership of securities-Officer Spaventa Andrew
Singular Genomics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Deerfield Management Company, L.P.(6.83%),James E. Flynn(6.83%), etc.
Singular Genomics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Domain Partners IX, L.P.(5.1%),Domain Associates, LLC(Less than 0.1%)
Singular Genomics | 4: Statement of changes in beneficial ownership of securities-Chief Commercial Officer Ropp Sam
Singular Genomics | 4: Statement of changes in beneficial ownership of securities-Chief Financial Officer Meeter Dalen
Singular Genomics | 4: Statement of changes in beneficial ownership of securities-Officer Glezer Eli N.
Singular Genomics | 4: Statement of changes in beneficial ownership of securities-Chief Executive Officer Spaventa Andrew
Singular Genomics | 4: Statement of changes in beneficial ownership of securities-Chief Executive Officer Spaventa Andrew
Singular Genomics | 4: Statement of changes in beneficial ownership of securities-Officer Glezer Eli N.
Singular Genomics | 3: Initial statement of beneficial ownership of securities-Chief Operating Officer Ghai Jyotsna
No Data